166 related articles for article (PubMed ID: 18086662)
1. Suppression of v-Src transformation by andrographolide via degradation of the v-Src protein and attenuation of the Erk signaling pathway.
Liang FP; Lin CH; Kuo CD; Chao HP; Fu SL
J Biol Chem; 2008 Feb; 283(8):5023-33. PubMed ID: 18086662
[TBL] [Abstract][Full Text] [Related]
2. U0126 reverses Ki-ras-mediated transformation by blocking both mitogen-activated protein kinase and p70 S6 kinase pathways.
Fukazawa H; Uehara Y
Cancer Res; 2000 Apr; 60(8):2104-7. PubMed ID: 10786668
[TBL] [Abstract][Full Text] [Related]
3. Differential requirements of the MAP kinase and PI3 kinase signaling pathways in Src- versus insulin and IGF-1 receptors-induced growth and transformation of rat intestinal epithelial cells.
Nguyen KT; Wang WJ; Chan JL; Wang LH
Oncogene; 2000 Nov; 19(47):5385-97. PubMed ID: 11103940
[TBL] [Abstract][Full Text] [Related]
4. MEK mediates v-Src-induced disruption of the actin cytoskeleton via inactivation of the Rho-ROCK-LIM kinase pathway.
Pawlak G; Helfman DM
J Biol Chem; 2002 Jul; 277(30):26927-33. PubMed ID: 12011049
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronan activates cell motility of v-Src-transformed cells via Ras-mitogen-activated protein kinase and phosphoinositide 3-kinase-Akt in a tumor-specific manner.
Sohara Y; Ishiguro N; Machida K; Kurata H; Thant AA; Senga T; Matsuda S; Kimata K; Iwata H; Hamaguchi M
Mol Biol Cell; 2001 Jun; 12(6):1859-68. PubMed ID: 11408591
[TBL] [Abstract][Full Text] [Related]
6. Cyclic AMP signaling reduces sirtuin 6 expression in non-small cell lung cancer cells by promoting ubiquitin-proteasomal degradation via inhibition of the Raf-MEK-ERK (Raf/mitogen-activated extracellular signal-regulated kinase/extracellular signal-regulated kinase) pathway.
Kim EJ; Juhnn YS
J Biol Chem; 2015 Apr; 290(15):9604-13. PubMed ID: 25713071
[TBL] [Abstract][Full Text] [Related]
7. Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells.
Rice PL; Washington M; Schleman S; Beard KS; Driggers LJ; Ahnen DJ
Cancer Res; 2003 Feb; 63(3):616-20. PubMed ID: 12566304
[TBL] [Abstract][Full Text] [Related]
8. cAMP activates TRPC6 channels via the phosphatidylinositol 3-kinase (PI3K)-protein kinase B (PKB)-mitogen-activated protein kinase kinase (MEK)-ERK1/2 signaling pathway.
Shen B; Kwan HY; Ma X; Wong CO; Du J; Huang Y; Yao X
J Biol Chem; 2011 Jun; 286(22):19439-45. PubMed ID: 21487005
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of cell cycle regulation by v-Src.
Riley D; Carragher NO; Frame MC; Wyke JA
Oncogene; 2001 Sep; 20(42):5941-50. PubMed ID: 11593401
[TBL] [Abstract][Full Text] [Related]
10. Src kinase integrates PI3K/Akt and MAPK/ERK1/2 pathways in T3-induced Na-K-ATPase activity in adult rat alveolar cells.
Lei J; Ingbar DH
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L765-71. PubMed ID: 21840963
[TBL] [Abstract][Full Text] [Related]
11. Constitutively active Galpha16 stimulates STAT3 via a c-Src/JAK- and ERK-dependent mechanism.
Lo RK; Cheung H; Wong YH
J Biol Chem; 2003 Dec; 278(52):52154-65. PubMed ID: 14551213
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine phosphorylation of cofilin at Y68 by v-Src leads to its degradation through ubiquitin-proteasome pathway.
Yoo Y; Ho HJ; Wang C; Guan JL
Oncogene; 2010 Jan; 29(2):263-72. PubMed ID: 19802004
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of MEK/ERK1/2 signalling alters endothelial nitric oxide synthase activity in an agonist-dependent manner.
Cale JM; Bird IM
Biochem J; 2006 Sep; 398(2):279-88. PubMed ID: 16716148
[TBL] [Abstract][Full Text] [Related]
14. Extracellular signal-regulated kinase activation during renal ischemia/reperfusion mediates focal adhesion dissolution and renal injury.
Alderliesten M; de Graauw M; Oldenampsen J; Qin Y; Pont C; van Buren L; van de Water B
Am J Pathol; 2007 Aug; 171(2):452-62. PubMed ID: 17620366
[TBL] [Abstract][Full Text] [Related]
15. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
16. Suppression of urokinase expression and invasion by a soybean Kunitz trypsin inhibitor are mediated through inhibition of Src-dependent signaling pathways.
Inagaki K; Kobayashi H; Yoshida R; Kanada Y; Fukuda Y; Yagyu T; Kondo T; Kurita N; Kitanaka T; Yamada Y; Sakamoto Y; Suzuki M; Kanayama N; Terao T
J Biol Chem; 2005 Sep; 280(36):31428-37. PubMed ID: 16002410
[TBL] [Abstract][Full Text] [Related]
17. Src-mediated cross-talk between farnesoid X and epidermal growth factor receptors inhibits human intestinal cell proliferation and tumorigenesis.
Peng Z; Raufman JP; Xie G
PLoS One; 2012; 7(10):e48461. PubMed ID: 23119029
[TBL] [Abstract][Full Text] [Related]
18. Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation.
Kim M; Tezuka T; Tanaka K; Yamamoto T
Oncogene; 2004 Mar; 23(9):1645-55. PubMed ID: 14661060
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
[TBL] [Abstract][Full Text] [Related]
20. Suppression of urokinase receptor expression by bikunin is associated with inhibition of upstream targets of extracellular signal-regulated kinase-dependent cascade.
Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
Eur J Biochem; 2002 Aug; 269(16):3945-57. PubMed ID: 12180971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
